United States · FDA National Drug Code directory

Divalproex Sodium

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
29300-140_8e888ed9-2d55-4e95-ba7b-8b437481c947
Product NDC
29300-140
Form
TABLET, DELAYED RELEASE
Composition / generic term
Divalproex Sodium
Labeler
Unichem Pharmaceuticals (USA), Inc.
Marketing category
ANDA
Marketing start / end (source format)
20111001
Source listing expiry
20271231

Source-listed ingredients

  • DIVALPROEX SODIUM — 500 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 100 TABLET, DELAYED RELEASE in 1 BOTTLE, PLASTIC (29300-140-01) · 29300-140-01
  • 500 TABLET, DELAYED RELEASE in 1 BOTTLE, PLASTIC (29300-140-05) · 29300-140-05
  • 1000 TABLET, DELAYED RELEASE in 1 BOTTLE, PLASTIC (29300-140-10) · 29300-140-10

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →